Delivery Order SPE2DB22D9205-SPE2DB25FZF71

Award Date 11/1/24
Potential Completion Date 11/25/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,342.50 contract is for the supply of Xolair 150 mg/1.2 ml powder for injection to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $37,224.96, is for the delivery of Xolair 150 mg/1.2 ml powder vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is valued at $82,661.00 and covers the delivery of Xolair 150 mg/1.2 ml powder vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,284.40, is for the delivery of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/1.2 ml powder vials, which are used to treat respiratory conditions. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of Xolair 150 mg/ml syringes and is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $74,275.20, is for the delivery of Xolair 150 mg/1.2 ml powder for injection. The contract has a period of performance through June 4, 2024 and is a firm fixed-price delivery order. This award is part of a larger, single-award indefinite delivery contract (IDC) the DLA has with DMS Pharmaceutical...
This is a $12,379.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of Xolair 150 mg/ml syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,948.00 firm fixed-price contract is for the delivery of Xolair 150 mg/1.2 ml powder vials, a specialized pharmaceutical product used to treat certain medical conditions. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with DLA valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $39,677.28, is for the delivery of XOLAIR 150 mg/1.2 ml powder for injection to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under...
  • SPE2DB22D9205
    Indefinite Delivery Contract
  • SPE2DB22D9205-SPE2DB25FZF71
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,853.20, is for the delivery of Xolair 150 mg/1.2 ml powder for injection.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, the company has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA.

Generated 1/31/25, 9:22 AM